The suppression effects of thalidomide on human lung fibroblasts: Cell proliferation, vascular endothelial growth factor release, and collagen production

Lung

Volumn 191, Issue 4, 2013, Pages 361-368

  Tseng, Ching Min ^a   Hsiao, Yi Han ^a   Su, Vincent Yi Fong ^a   Su, Kang Cheng ^a   Wu, Yu Chung ^a,b   Chang, Kuo Ting ^a   Perng, Diahn Warng ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Lung fibroblasts; Smad3; STAT3; TGF 1; Thalidomide

Indexed keywords

COLLAGEN; MESSENGER RNA; PROTEIN P42; PROTEIN P44; SMAD3 PROTEIN; STAT3 PROTEIN; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; GRANULATION TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WOUND CLOSURE;

EID: 84880835558     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9477-1     Document Type: Article

References (27)

1. Law JH, Barnhart K, Rowlett W, de la Rocha O, Lowenberg S (1993) Increased frequency of obstructive airway abnormalities with long-term tracheostomy. Chest 104(1):136-138
2. Liu H, Chen JC, Holinger LD, Gonzalez-Crussi F (1995) Histopathologic fundamentals of acquired laryngeal stenosis. Pediatr Pathol Lab Med 15(5):655-677
3. Karagiannidis C, Velehorschi V, Obertrifter B, Macha HN, Linder A, Freitag L (2006) High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest 129(5):1298-1304
4. Pokharel RP, Maeda K, Yamamoto T, Noguchi K, Iwai Y, Nakamura H, Iijima K (1999) Expression of vascular endothelial growth factor in exuberant tracheal granulation tissue in children. J Pathol 188(1):82-86
5. Lee YC, Hung MH, Liu LY, Chang KT, Chou TY, Wang YC, Wu YC, Lai CL, Tsai CC, Su KC, Perng DW (2011) The roles of transforming growth factor-beta and vascular endothelial growth factor in the tracheal granulation formation. Pulm Pharmacol Ther 24(1):23-31
6. Galluccio G, Lucantoni G, Battistoni P, Paone G, Batzella S, Lucifora V, Dello Iacono R (2009) Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg 35(3):429-433
7. Ciccone AM, De Giacomo T, Venuta F, Ibrahim M, Diso D, Coloni GF, Rendina EA (2004) Operative and non-operative treatment of benign subglottic laryngotracheal stenosis. Eur J Cardiothorac Surg 26(4):818-822
8. Grillo HC, Donahue DM, Mathisen DJ, Wain JC, Wright CD (1995) Postintubation tracheal stenosis. Treatment and results. J Thorac Cardiovasc Surg 109(3):486-492 discussion 492-483
9. Rea F, Callegaro D, Loy M, Zuin A, Narne S, Gobbi T, Grapeggia M, Sartori F (2002) Benign tracheal and laryngotracheal stenosis: surgical treatment and results. Eur J Cardiothorac Surg 22(3):352-356
10. Ward RF, April MM (1998) Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol 44(3):221-226
11. Shlomi D, Peled N, Shitrit D, Bendayan D, Amital A, Kramer MR (2008) Protective effect of immunosuppression on granulation tissue formation in metallic airway stents. Laryngoscope 118(8):1383-1388
12. Keifer JA, Guttridge DC, Ashburner BP, Baldwin AS Jr (2001) Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J Biol Chem 276(25):22382-22387
13. Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163(1):380-386
14. Or R, Feferman R, Shoshan S (1998) Thalidomide reduces vascular density in granulation tissue of subcutaneously implanted polyvinyl alcohol sponges in guinea pigs. Exp Hematol 26(3):217-221
15. Bartlett JB, Dredge K, Dalgleish AG (2004) The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer 4(4):314-322
16. Strauss RM, Bate J, Nischal KK, Clayton T, Gooi J, Darling JC, Newton-Bishop JA (2006) A child with laryngo-onychocutaneous syndrome partially responsive to treatment with thalidomide. Br J Dermatol 155(6):1283-1286
17. Moreira AL, Friedlander DR, Shif B, Kaplan G, Zagzag D (1999) Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro. J Neurooncol 43(2):109-114
18. Miyata M, Tamura E, Motoki K, Nagata K, Yamazoe Y (2003) Thalidomide-induced suppression of embryo fibroblast proliferation requires CYP1A1-mediated activation. Drug Metab Dispos 31(4):469-475
19. Fuchida SI, Shimazaki C, Hirai H, Akamatsu S, Yamada N, Uchida R, Okano A, Okamoto M, Inaba T, Taniwaki M (2008) The effects of thalidomide on chemotactic migration of multiple myeloma cell lines. Int J Lab Hematol 30(3):220-229
20. Komorowski J, Jerczynska H, Siejka A, Baranska P, Lawnicka H, Pawlowska Z, Stepien H (2006) Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells. Life Sci 78(22):2558-2563
21. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1(5):260-266
22. Verrecchia F, Chu ML, Mauviel A (2001) Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276(20):17058-17062
23. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342(18):1350-1358
24. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18(7):816-827
25. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13):2000-2008
26. Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB (2003) VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17(11):1562-1564
27. Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, Marrero MB, Caldwell RB (2000) Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem 275(43):33189-33192